Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:403-407

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cribbs, L. L.
Right arrow Articles by Satin, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cribbs, L. L.
Right arrow Articles by Satin, J.
Related Collections
Right arrow Developmental biology
Right arrow Gene expression
Right arrow Ion channels/membrane transport
(Circulation Research. 2001;88:403.)
© 2001 American Heart Association, Inc.


Cellular Biology

Identification of the T-Type Calcium Channel (CaV3.1d) in Developing Mouse Heart

Leanne L. Cribbs, Beverly L. Martin, Elizabeth A. Schroder, Bradley B. Keller, Brian P. Delisle, Jonathan Satin

From the Cardiovascular Institute (L.L.C., B.L.M.), Loyola University Medical Center, Maywood, Ill, and the Departments of Pediatrics (E.A.S., B.B.K.) and Physiology (B.P.D., J.S.), University of Kentucky College of Medicine, Lexington, Ky.

Correspondence to Jonathan Satin, PhD, Department of Physiology, MS-508, University of Kentucky College of Medicine, Lexington, KY 40536-0298. E-mail jsatin1{at}pop.uky.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—During cardiac development, there is a reciprocal relationship between cardiac morphogenesis and force production (contractility). In the early embryonic myocardium, the sarcoplasmic reticulum is poorly developed, and plasma membrane calcium (Ca2+) channels are critical for maintaining both contractility and excitability. In the present study, we identified the CaV3.1d mRNA expressed in embryonic day 14 (E14) mouse heart. CaV3.1d is a splice variant of the {alpha}1G, T-type Ca2+ channel. Immunohistochemical localization showed expression of {alpha}1G Ca2+ channels in E14 myocardium, and staining of isolated ventricular myocytes revealed membrane localization of the {alpha}1G channels. Dihydropyridine-resistant inward Ba2+ or Ca2+ currents were present in all fetal ventricular myocytes tested. Regardless of charge carrier, inward current inactivated with sustained depolarization and mirrored steady-state inactivation voltage dependence of the {alpha}1G channel expressed in human embryonic kidney-293 cells. Ni2+ blockade discriminates among T-type Ca2+ channel isoforms and is a relatively selective blocker of T-type channels over other cardiac plasma membrane Ca2+ handling proteins. We demonstrate that 100 µmol/L Ni2+ partially blocked {alpha}1G currents under physiological external Ca2+. We conclude that {alpha}1G T-type Ca2+ channels are functional in midgestational fetal myocardium.


Key Words: calcium channel • cardiac development • low-voltage-activated Ca2+ channel


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
L-type and T-type calcium (Ca2+) channels comprise two broadly classified families of voltage-gated Ca2+ channels. L-type Ca2+ channel expression and function are well characterized in cardiac myocytes, where L-type channels mediate plasma membrane influx of extracellular Ca2+. Plasma membrane influx of Ca2+ leads to Ca2+-induced Ca2+ release, which in turn regulates cardiac contractility. The L-type Ca2+ channels also are an important therapeutic target for management of a variety of cardiovascular disorders. In contrast to L-type channels, T-type Ca2+ channel expression and function are poorly understood, and the therapeutic potential of T-type Ca2+ channels in mature myocardium is unknown. Nonetheless, earlier studies showed that de novo expression of T-type Ca2+ channels may contribute to the cardiac hypertrophic phenotype.1 More recently, Nattel and colleagues2 3 suggested that T-type Ca2+ current might contribute to arrhythmogenesis in patients exhibiting atrial fibrillation.

L-type and T-type Ca2+ channels are perhaps most clearly distinguished by their respective voltage range of activation. L-type Ca2+ channels activate only with strong depolarizations ({approx}>-50 mV), corresponding to the plateau of the action potential. In contrast, T-type Ca2+ channels activate with weak depolarizations ({approx}>-80 mV). In fact, we recently demonstrated that T-type Ca2+ channels activate at slightly more negative potentials than even cardiac Na+ channel currents.4 This low-voltage-activation range of T-type Ca2+ channels allows them to provide a substantial inward, depolarizing current in the late phase of diastole. Thus it is likely that T-type Ca2+ current contributes to the initiation of the action potential upstroke in pacemaker cells.5 6 7

Embryonic ventricular myocytes are capable of automatic activity, in contrast to normal adult myocardium. Studies on embryonic chick ventricular myocytes clearly show the expression of T-type Ca2+ current8 9 ; however, the literature from embryonic mouse heart is controversial. Nuss and Marbán10 showed substantial T-type Ca2+ channel expression, but Davies et al11 were unable to detect T-type current. The recent molecular identification of T-type Ca2+ channels12 13 facilitates unequivocal detection of channel gene expression. The {alpha}1G channel is encoded by the CaV3.1 gene,12 and there are 4 distinct splice variants in the domain III-IV connecting loop in rodents and humans.14 15 16 Our recent studies showed that mouse atrial tumor (AT-1) cells functionally express {alpha}1G-d (CaV3.1d).17 AT-1 cells have an excitability pattern that parallels embryonic ventricular myocytes, suggesting that developing myocardium may also express {alpha}1G channels.

We undertook the present study to evaluate the expression of T-type Ca2+ channels in embryonic myocytes. We show that the T-type Ca2+ channel splice variant {alpha}1G-d is expressed in embryonic day 13 (E13) to E14.5 mouse ventricle, and we present data consistent with the hypothesis that Ca2+ entry via the T-type channel may contribute to excitability in the developing myocardium.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Tissue Harvest
E12.5 to E13 mouse hearts were dissected free of connective tissues, and ventricles were separated from atria. For isolation of total RNA, whole ventricles were immersed in Trizol reagent (GIBCO-BRL) and homogenized. For immunohistochemistry, E13 hearts were removed, embedded in OCT compound, and rapidly frozen in a dry-ice bath. For cell isolation for patch-clamp recordings and immunocytochemistry, ventricles from 3 to 8 embryos were minced and quickly placed into nominally Ca2+-free digestion buffer containing 0.5 mg/mL collagenase (type II, Worthington) and 1 mg/mL pancreatin (GIBCO-BRL) for two 15-minute cycles.

Molecular Characterization
Total E13 ventricular RNA was characterized by reverse transcriptase–polymerase chain reaction (RT-PCR), as described elsewhere.17

Immunostaining
Type-specific antibodies 2xG1 (anti-{alpha}1G) and 2xH1 (anti-{alpha}1H), prepared against peptides derived from the {alpha}1G and {alpha}1H T-type channel sequences12 13 (for 2xG1: FVCQGEDTRNITNKSDCAEAS and 2xH1: YYCEGPDTRNISTKAQCRAAH), were immunoaffinity-purified commercially (Bethyl Laboratories). Monoclonal antibody MF 20 (Developmental Studies Hybridoma Bank, University of Iowa) was used to stain myofibrils using a rhodamine-conjugated secondary antibody (Molecular Probes). For additional details, see the online data supplement available at http://www.circresaha.org.

Electrophysiology
Digested tissue yielded a large fraction of single, spontaneously beating cells in culture medium (DMEM with 10% FBS, 100 U/mL penicillin, and 100 mg/mL streptomycin). Cells were used within 48 hours of isolation. Cells in culture medium were rinsed with recording buffer for T-type Ca2+ current (in mmol/L: CsCl 140, CaCl2 2.5, HEPES 10, tetrodotoxin [TTX] 0.036, nifedipine 0.001, and E-4031 0.005; pH 7.4). The pipette contained 140 mmol/L CsCl, 5 mmol/L EGTA, and 5 mg ATP; pH 7.4). All recordings were at room temperature (20°C to 22°C). Mean cell capacitance was 9.1±1.6 pF, n=12. Additional details of recording and data analysis can be found elsewhere.17 18

An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Assay of total E12 to E14 ventricular myocyte RNA by RT-PCR and DNA sequencing allows an unequivocal assessment of T-type Ca2+ channel mRNA expression. We used a strategy identical to that used by Satin and Cribbs17 to identify T-type Ca2+ channels in fetal mouse ventricle. Mouse E12.5 to E14 ventricular myocytes express the {alpha}1G-d splice variant, as shown previously for AT-1 cells (Figure 1Down). Even though the PCR primers used can amplify all 3 known T-type channels,19 no other low-voltage-activated channels or splice variants were discovered.



View larger version (47K):
[in this window]
[in a new window]
 
Figure 1. RT-PCR of E14 mouse heart RNA. Total RNA (1 µg) was converted to cDNA using Moloney murine leukemia virus–reverse transcriptase, then PCR was done using primers that amplify the III-IV interdomain loop of {alpha}1G, {alpha}1H, and {alpha}1I. The PCR product was run on a 0.8% agarose/TBE gel (lane 2) along with 100-bp ladder (lane M) and negative control reaction, in which reverse transcriptase was omitted (lane 1). DNA sequencing of the PCR product identified it as {alpha}1G-d, 1 of 4 known splice variants of this region, shown below the gel.

The expression of mRNA does not always correlate with protein expression. To confirm protein expression, we used antibodies (2xG1 and 2xH1) to evaluate expression and localization of T-type channels in embryonic heart. Figure 2DDown shows a sagittal section of ventricle with vigorous staining for {alpha}1G. We also noted staining of vasculature and atrial walls (Figure 2BDown). Preimmune controls (Figures 2ADown and 2CDown) and anti-{alpha}1H antibodies did not stain (not shown). The staining of {alpha}1G was blocked completely by 2xG1 peptide–absorbed antibody (Figure 2EDown), whereas 2xH1 peptide had no effect on 2xG1 staining (Figure 2FDown). To additionally control for antibody specificity, 2xG1 clearly stained human embryonic kidney (HEK) cells stable-transfected with {alpha}1G; in contrast, HEK cells expressing {alpha}1H or untransfected HEK cells did not show 2xG1 staining (see the online data supplement). We also stained isolated ventricular myocytes using the 2xG1 antibody (Figure 3Down). Cells were costained with MF 20, a monoclonal antibody to myosin heavy chain, to confirm their identity as myocytes (Figure 3ADown). Figure 3BDown shows the expected plasma membrane localization of {alpha}1G, a staining pattern distinct from the myofibrillar staining with MF 20. Taken together, the RT-PCR and immunostaining results show that embryonic ventricular myocardium expresses the {alpha}1G-d splice variant.



View larger version (168K):
[in this window]
[in a new window]
 
Figure 2. Immunostaining of E14 mouse heart. Cryosections (14 µm) of whole heart were stained with either preimmune serum (A and C) or 2xG1 polyclonal antiserum (1:1000, B and D). The VIP substrate produces a positive violet color. Shown are sagittal views of atrial region (x112, A and B) or ventricle (x280, C and D). Absorption of anti-{alpha}1G antiserum with 50 µmol/L 2xG1 peptide completely blocked staining (E); in contrast, absorption with 50 µmol/L 2xH1 peptide had no effect on 2xG1 staining (F).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Immunostain of cultured E13 mouse ventricular myocyte. Isolated cells were stained with either MF 20 (myosin heavy chain monoclonal antibody, rhodamine-conjugated secondary antibody) (A) or 2xG1 (FITC-conjugated secondary antibody) (B). Magnification is x1120.

We performed whole-cell mode patch-clamp recordings of embryonic ventricular myocytes to evaluate {alpha}1G-d channel function. To isolate T-type channel current from voltage-gated Na+, L-type Ca2+, and K+ currents, we bathed cells in Na+-free bath containing 2.5 mmol/L Ba2+, 30 µmol/L TTX, and 100 µmol/L nifedipine. Figure 4Down shows representative recordings of T-type Ca2+ current. Channel kinetics (Figure 4ADown) and the steady-state inactivation voltage dependence are consistent with scoring this current as a T-type Ca2+ channel current. The voltage dependence of activation is depolarized-shifted (midpoint=-22 mV; Figure 4BDown), but this is a consistent trend observed for voltage-gated Na+ and Ca2+ channels in developing myocardium.8 20 The presence of inactivating Ba2+ current in 100 µmol/L nifedipine (Figures 4ADown and 4CDown) is unequivocal evidence that the current is not through L-type Ca2+ channels.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 4. Inward Ba2+ current is 100 µmol/L DHP–resistant and inactivating in fetal ventricular myocytes. A, Top left, family of currents elicited from Vhold -100 mV to Vtest of -40 and 0 mV demonstrates characteristic crossover of currents. Smooth curves are single exponential fit with {tau}=32 and 19 ms at Vtest -40 (blue) and 0 mV (red), respectively. Vtest indicated above currents elicited for -30, -20, and -10 mV. Time to peak and rate of macroscopic current decay increased with increasing depolarization. Bars=20 pA, 20 ms. B, Pooled current-voltage curve fitted with modified Boltzmann distribution. Midpoint=-22 mV, slope=8.4 (n=12). C, Pooled steady-state inactivation curves of Ba2+ current in the presence of 100 µmol/L nifedipine. Midpoint=-67.2 mV, slope=9.7 (n=6). D, Ni2+ sensitivity of IT in fetal ventricular myocytes. Representative steady-state inactivation curves in control and 100 µmol/L Ni2+. Vtest=-10 mV. Midpoints=-67.5 and -74 in control and 100 µmol/L Ni2+, respectively.

We used Ni2+ blockade as an indication of T-type isoform expression in fetal cardiomyocytes. Ni2+, 200 µmol/L, blocks the {alpha}1G Ca2+ channel current by {approx}50%; in contrast, {approx}10 µmol/L Ni2+ is sufficient for half-block of the {alpha}1H T-type Ca2+ current.21 In E12.5 to E14 ventricular myocytes, 100 µmol/L Ni2+ blocks T-type Ca2+ current by 38.3±5.8% (Figure 4DUp; n=3). Ni2+-blocked and -unblocked currents have a comparable voltage dependence of inactivation consistent with a uniform dihydropyridine (DHP)-resistant channel population. On the basis of Ni2+ blockade and current kinetics coupled with the molecular identification and immunohistochemical data (Figures 1 through 3UpUpUp), we assign the T-type Ca2+ current in embryonic ventricular myocardium as an {alpha}1G-d current.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
CaV3.1d is a splice variant of the {alpha}1G, T-type Ca2+ channel. In this study we demonstrate for the first time, to our knowledge, the following observations: (1) {alpha}1G mRNA and protein are expressed in developing fetal cardiac myocytes; (2) {alpha}1G is functionally expressed, as evidenced by T-type Ca2+ currents in E12.5 to E14 ventricular myocytes; and (3) {approx}100 µmol/L Ni2+ half-blocks this T-type Ca2+ current. This report provides an experimental foundation for the hypothesis that T-type Ca2+ current, specifically {alpha}1G-d, contributes to plasma membrane Ca2+ flux for contraction in the developing myocardium.

Our observation that E12.5 to E14 ventricular myocytes express robust T-type Ca2+ current is controversial. Nuss and Marbán10 showed that late fetal and neonatal mouse myocytes express T-type Ca2+ current (IT), but the only other study of murine E12 to E14 ventricle detected no IT expression.11 Recently, Leranguer et al22 and Pignier and Potreau23 showed progressive reduction of DHP-resistant current from postnatal day 4 through adulthood. Under conditions of millimolar extracellular Ca2+, it may be difficult to separate T- from L-type Ca2+ channel current in ventricular myocytes. Nuss and Marbán10 showed the presence of a 10 µmol/L nitrendipine-resistant Ba2+ current in fetal cardiomyocytes. Furthermore, this current inactivated with sustained depolarization and as a function of steady-state holding potential. Similarly, we observed a 100 µmol/L nifedipine-resistant inactivating Ba2+ current. Furthermore, the steady-state inactivation voltage dependence was similar to our steady-state inactivation measurements of {alpha}1G expressed heterologously in HEK293 cells.4 17 We increased the nifedipine dose to 100 µmol/L to completely block L-type Ca2+ current24 25 and exposed the cells to drug for >5 minutes to prevent confusion of use-dependent blockade of L-type channels with IT.26 Therefore, the inward Ca2+ or Ba2+ current that we observe is DHP-resistant, thereby excluding L-type channels. Furthermore, the current we measure inactivates both by sustained depolarization and by steady-state holding potential; these properties exclude the unidentified current in fetal myocytes in the {alpha}1C knockout mouse.27 Finally, the activity of this current in the presence of 30 µmol/L TTX excludes a contribution from ICa,TTX.28 We also suggest that the novel fetal ICa,fe29 is in fact {alpha}1G T-type current. Given that heterologously expressed current through {alpha}1G is DHP resistant30 and that kinetic and steady-state inactivation properties from fetal ventricular myocytes mirror our earlier studies of {alpha}1G current, we conclude that fetal ventricular myocytes express functional T-type Ca2+ current. This assignment is based on a combination of the exclusion of known inward current carriers and parallels the reported properties of heterologously expressed T-type channel current.

One procedure common between the present study and the study by Nuss and Marbán10 is that spontaneously active cells were selected for study. Automatic activity is a well-described property of neonatal ventricular myocytes.31 32 We find it interesting to note the ongoing correlation of T-type Ca2+ channel expression with pacemaker cells from heart5 6 8 and noncardiac tissues.33 Furthermore, the {alpha}1G-d splice variant that we now identify in fetal ventricular myocytes is the same splice variant that we previously identified in the murine AT-1 cell line.17 As with fetal myocytes, AT-1 cells in culture fire spontaneous action potentials.34 Finally, our present studies and the study by Nuss and Marbán10 corroborate earlier findings from chick that IT in early embryonic development has a depolarizing shifted voltage dependence of the macroscopic I-V curve.8 This creates an overlap of T- and L-type Ca2+ currents in the absence of DHP. In any case, our results unequivocally show that a particular splice variant of T-type Ca2+ channels is expressed in E13 ventricle and is a likely pathway for inward, DHP-resistant Ca2+ current.

There are 3 major plasma membrane transport mechanisms for inward Ca2+ flux in fetal cardiomyocytes: ICa,L, IT, and reverse-mode Na+-Ca2+ exchange. Unequivocal assessment of the relative contribution of these mechanisms is hindered by the lack of selective pharmacological agents. Ni2+ is relatively selective for IT compared with ICa,L and Na+-Ca2+ exchange, but it may also have subtle effects, particularly on ICa,L in the range of 100 µmol/L used in this study.35 Therefore, in the absence of selective T-type channel blockers, establishment of a role for T-type Ca2+ channels in developing myocardium may ultimately require a combination of molecular genetic approaches, including their complete ablation using knockout strategies and overexpression of {alpha}1G-d in mouse heart.


*    Acknowledgments
 
This work was supported by the American Heart Association (grant 0051434Z to L.L.C.) and the National Institutes of Health (National Research Service Award F32-HL 10200-02 to E.S. and grant HL63416 to J.S.). The authors thank Lindsay Burns and Joe Tinney for excellent technical assistance.


*    Footnotes
 
Original received October 17, 2000; revision received December 28, 2000; accepted December 28, 2000.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Nuss HB, Houser SR. T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res. 1993;73:777–782.[Abstract/Free Full Text]

2. Nattel S. Ionic determinants of atrial fibrillation and calcium channel abnormalities: cause, consequence, or innocent bystander? Circ Res. 1999;85:473–476.[Free Full Text]

3. Nattel S, Li D, Yue L. Basic mechanisms of atrial fibrillation: very new insights into very old ideas. Annu Rev Physiol. 2000;62:51–77.[Medline] [Order article via Infotrieve]

4. Zhang Y, Cribbs LL, Satin J. Arachidonic acid modulation of {alpha}1H, a cloned human T-type calcium channel. Am J Physiol Heart Circ Physiol. 2000;278:184–193.

5. Huser J, Blatter LA, Lipsius SL. Intracellular Ca2+ release contributes to automaticity in cat atrial pacemaker cells. J Physiol (Lond). 2000;524:415–422.[Abstract/Free Full Text]

6. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol. 1988;395:223–253.

7. Lei M, Brown H, Noble D. What role do T-type calcium channels play in cardiac pacemaker activity? In: Tsien RW, Clozel J-P, Nargeot J, eds. Low Voltage-Activated T-type Calcium Channels. Chester, UK: Adis International; 1996:103–109.

8. Kawano S, Dehaan RL. Developmental changes in the calcium currents in embryonic chick ventricular myocytes. J Membr Biol. 1991;120:17–28.[Medline] [Order article via Infotrieve]

9. Brotto MA, Creazzo TL. Ca2+ Transients in embryonic chick heart: contributions from Ca2+ channels and the sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol. 1996;270:518–525.

10. Nuss HB, Marbán E. Electrophysiological properties of neonatal mouse cardiac myocytes in primary culture. J Physiol. 1994;479:265–279.[Abstract/Free Full Text]

11. Davies MP, An RH, Doevendans P, Kubalak S, Chien KR, Kass RS. Developmental changes in ionic channel activity in the embryonic murine heart. Circ Res. 1996;78:15–25.[Abstract/Free Full Text]

12. Perez-Reyes E, Cribbs LL, Daud A, Lacerda AE, Barclay J, Williamson MP, Fox M, Rees M, Lee J-H. Molecular characterization of a neuronal low-voltage activated T-type calcium channel. Nature. 1998;391:896–900.[Medline] [Order article via Infotrieve]

13. Cribbs LL, Lee J-H, Yang J, Satin J, Zhang Y, Daud A, Barclay J, Williamson MP, Fox M, Rees M, Perez-Reyes E. Cloning and characterization of {alpha}1H from human heart, a member of the T-type calcium channel gene family. Circ Res. 1998;83:103–109.[Abstract/Free Full Text]

14. Lee JH, Daud AN, Cribbs LL, Lacerda AE, Pereverzev A, Klockner U, Schneider T, Perez-Reyes E. Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J Neurosci. 1999;19:1912–1921.[Abstract/Free Full Text]

15. Monteil A, Chemin J, Bourinet E, Nargeot J, Lory P. Identification of multiple human {alpha}1G isoforms of T-type calcium channels with distinct functional properties. Biophys J. 2000;78:199a. Abstract.

16. Cribbs LL, Gomora JC, Daud AN, Lee JH, Perez-Reyes E. Molecular cloning and functional expression of CaV3.1c, a T-type calcium channel from human brain. FEBS Lett.. 2000;466:54–58.[Medline] [Order article via Infotrieve]

17. Satin J, Cribbs LL. Identification of a T-type calcium channel isoform in murine atrial myocytes (AT-1). Circ Res. 2000;86:636–642.[Abstract/Free Full Text]

18. Delisle BP, Satin J. pH Modification of human T-type calcium channel gating. Biophys J.2000;78:1895–1905.

19. Lambert RC, McKenna F, Maulet Y, Talley EM, Bayliss DA, Cribbs LL, Lee J-H, Perez-Reyes E, Feltz A. Low-voltage-activated Ca2+ currents are generated by members of the CaVT subunit family ({alpha}1G/H) in rat primary sensory neurons. J Neurosci. 1998;18:8605–8613.[Abstract/Free Full Text]

20. Fujii S, Ayer RK Jr, DeHaan RL. Development of the fast sodium current in early embryonic chick heart cells. J Membr Biol. 1988;101:209–223.[Medline] [Order article via Infotrieve]

21. Lee J-H, Gomora JC, Cribbs LL, Perez-Reyes E. Nickel block of three cloned T-type calcium channels: low concentrations selectively block {alpha}1H. Biophys J. 1999;77:3034–3042.[Medline] [Order article via Infotrieve]

22. Leuranguer V, Monteil A, Bourinet E, Dayanithi G, Nargeot J. T-type calcium currents in rat cardiomyocytes during postnatal development: contribution to hormone secretion. Am J Physiol Heart Circ Physiol. 2000;279:H2540–H2548.[Abstract/Free Full Text]

23. Pignier C, Potreau D. Characterization of nifedipine-resistant calcium current in neonatal rat ventricular cardiomyocytes. Am J Physiol Heart Circ Physiol. 2000;279:H2259–H2268.[Abstract/Free Full Text]

24. Wasserstrom JA, Vites AM. The role of Na+-Ca2+ exchange in activation of excitation-contraction coupling in rat heart cells. J Physiol. 1996;493:529–542.[Abstract/Free Full Text]

25. Shen J-B, Jiang B, Pappano AJ. Comparison of L-Type calcium channel blockade by nifedipine and/or cadmium in guinea-pig ventricular myocytes. J Pharmacol Exp Ther. 2000;294:562–570.[Abstract/Free Full Text]

26. Mery P-F, Hove-Madsen L, Mazet J-L, Hanf R, Fischmeister R. Binding constants determined from Ca2+ current responses to rapid applications and washouts of nifedipine in frog cardiac myocytes. J Physiol. 1996;494:105–120.[Abstract/Free Full Text]

27. Seisenberger C, Specht V, Welling A, Platzer J, Pfeifer A, Kuhbandner S, Striessnig J, Klugbauer N, Feil R, Hofmann F. Functional embryonic cardiomyocytes after disruption of the L-type {alpha}1C (CaV1.2) calcium channel gene in the mouse. J Biol Chem. 2000;275:39193–39199.[Abstract/Free Full Text]

28. Aggarwal R, Shorofsky SR, Goldman L, Balke CW. Tetrodotoxin-blockable calcium currents in rat ventricular myocytes: a third type of cardiac cell sodium current. J Physiol. 1997;505:353–369.[Abstract/Free Full Text]

29. Tohse N, Masuda H, Sperelakis N. Novel isoform of Ca2+ channel in rat fetal cardiomyocytes. J Physiol. 1992;451:295–306.[Abstract/Free Full Text]

30. Lacinova L, Klugbauer N, Hofmann F. Regulation of the calcium channel {alpha}1G subunit by divalent cations and organic blockers. Neuropharmacology. 2000;39:1254–1266.[Medline] [Order article via Infotrieve]

31. Kamino K. Optical approaches to ontogeny of electrical activity and related functional organization during early heart development. Physiol Rev. 1991;71:53–91.[Abstract/Free Full Text]

32. DeHaan RL. Differentiation of excitable membranes. Curr Topics Dev Biol. 1980;16:117–164.[Medline] [Order article via Infotrieve]

33. Huegenard JR. Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol. 1996;58:329–348.[Medline] [Order article via Infotrieve]

34. Yang T, Wathen MS, Felipe A, Tamkun MM, Snyders DJ, Roden DM. K+ currents and K+ channel mRNA in cultured atrial cardiac myocytes (AT-1 Cells). Circ Res. 1994;75:870–878.[Abstract/Free Full Text]

35. Hobai IA, Hancox JC, Levi AJ. Inhibition by nickel of the L-type Ca2+ channel in guinea pig ventricular myocytes and effect of internal cAMP. Am J Physiol Heart Circ Physiol. 2000;279:692–701.




This article has been cited by other articles:


Home page
Circ. Res.Home page
E. Schroder, M. Byse, and J. Satin
L-Type Calcium Channel C Terminus Autoregulates Transcription
Circ. Res., June 19, 2009; 104(12): 1373 - 1381.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C.-S. Chiang, C.-H. Huang, H. Chieng, Y.-T. Chang, D. Chang, J.-J. Chen, Y.-C. Chen, Y.-H. Chen, H.-S. Shin, K. P. Campbell, et al.
The CaV3.2 T-Type Ca2+ Channel Is Required for Pressure Overload-Induced Cardiac Hypertrophy in Mice
Circ. Res., February 27, 2009; 104(4): 522 - 530.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Jaleel, H. Nakayama, X. Chen, H. Kubo, S. MacDonnell, H. Zhang, R. Berretta, J. Robbins, L. Cribbs, J. D. Molkentin, et al.
Ca2+ Influx Through T- and L-Type Ca2+ Channels Have Different Effects on Myocyte Contractility and Induce Unique Cardiac Phenotypes
Circ. Res., November 7, 2008; 103(10): 1109 - 1119.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Y.-Q. Zhang and K. D. Sarge
Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies
J. Cell Biol., October 23, 2008; 182(1): 35 - 39.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
R. Rapila, T. Korhonen, and P. Tavi
Excitation-Contraction Coupling of the Mouse Embryonic Cardiomyocyte
J. Gen. Physiol., September 29, 2008; 132(4): 397 - 405.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
T. Korhonen, R. Rapila, and P. Tavi
Mathematical Model of Mouse Embryonic Cardiomyocyte Excitation-Contraction Coupling
J. Gen. Physiol., September 29, 2008; 132(4): 407 - 419.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. E. Mangoni and J. Nargeot
Genesis and Regulation of the Heart Automaticity
Physiol Rev, July 1, 2008; 88(3): 919 - 982.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
H. Sun, D. Varela, D. Chartier, P. C. Ruben, S. Nattel, G. W. Zamponi, and N. Leblanc
Differential Interactions of Na+ Channel Toxins with T-type Ca2+ Channels
J. Gen. Physiol., July 1, 2008; 132(1): 101 - 113.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. J. Wang and E. A. Sobie
Mathematical model of the neonatal mouse ventricular action potential
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2565 - H2575.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Kapur and K. Banach
Inositol-1,4,5-trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes
J. Physiol., June 15, 2007; 581(3): 1113 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Crump, R. N. Correll, E. A. Schroder, W. C. Lester, B. S. Finlin, D. A. Andres, and J. Satin
L-type calcium channel {alpha}-subunit and protein kinase inhibitors modulate Rem-mediated regulation of current
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1959 - H1971.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Laleve, M. C. Rebsamen, S. Barrere-Lemaire, E. Perrier, J. Nargeot, J.-P. Benitah, and M. F. Rossier
Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes
Cardiovasc Res, August 1, 2005; 67(2): 216 - 224.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. I. Brueggemann, B. L. Martin, J. Barakat, K. L. Byron, and L. L. Cribbs
Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H923 - H935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Niwa, K. Yasui, T. Opthof, H. Takemura, A. Shimizu, M. Horiba, J.-K. Lee, H. Honjo, K. Kamiya, and I. Kodama
Cav3.2 subunit underlies the functional T-type Ca2+ channel in murine hearts during the embryonic period
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2257 - H2263.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Ferron, V. Capuano, Y. Ruchon, E. Deroubaix, A. Coulombe, and J.-F. Renaud
Angiotensin II Signaling Pathways Mediate Expression of Cardiac T-Type Calcium Channels
Circ. Res., December 12, 2003; 93(12): 1241 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. M. Zhang, L. Shang, C. Hartzell, M. Narlow, L. Cribbs, and S. C. Dudley Jr.
Characterization and regulation of T-type Ca2+ channels in embryonic stem cell-derived cardiomyocytes
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2770 - H2779.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Xu, A. Welling, S. Paparisto, F. Hofmann, and N. Klugbauer
Enhanced Expression of L-type Cav1.3 Calcium Channels in Murine Embryonic Hearts from Cav1.2-deficient Mice
J. Biol. Chem., October 17, 2003; 278(42): 40837 - 40841.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A.G. van der Heyden, M. J.A. van Kempen, Y. Tsuji, M. B. Rook, H. J. Jongsma, and T. Opthof
P19 embryonal carcinoma cells: a suitable model system for cardiac electrophysiological differentiation at the molecular and functional level
Cardiovasc Res, May 1, 2003; 58(2): 410 - 422.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Perez-Reyes
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
Physiol Rev, January 1, 2003; 83(1): 117 - 161.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cribbs, L. L.
Right arrow Articles by Satin, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cribbs, L. L.
Right arrow Articles by Satin, J.
Related Collections
Right arrow Developmental biology
Right arrow Gene expression
Right arrow Ion channels/membrane transport